Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.2914
Delayed Data
As of 3:12pm ET
 -0.0081 / -2.70%
Today’s Change
0.21
Today|||52-Week Range
2.97
-82.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.4M

Company Description

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.

Contact Information

Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard
Hayward California 94545
P:(510) 856-5600
Investor Relations:
151085656005621

Employees

Shareholders

Other institutional11.84%
Mutual fund holders1.99%
Individual stakeholders0.19%

Top Executives

John Craig ThompsonPresident, CEO & Executive Director
May LiuCAO, Senior VP-Finance & Administration
Nikhil AgarwalHead-Investor Relations
Bradley A. BugdanowitzSecretary